Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.64851 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.58128 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.59236 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.1056 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.51414 | 71 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.44245 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.59706 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.53792 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.51159 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.58231 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.69177 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.74142 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.57081 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.70373 | 73 |